Buys | $215,684 | 6 | 38 |
Sells | $653,601 | 10 | 62 |
Lee Frank D. | Chief Executive Officer | 1 | $99,994 | 0 | $0 | $99,994 |
BIGAL MARCELO | director | 2 | $60,868 | 0 | $0 | $60,868 |
YANG MICHAEL J. | director | 1 | $25,800 | 0 | $0 | $25,800 |
Froimson Mark | director | 1 | $16,212 | 0 | $0 | $16,212 |
Brege Laura | director | 1 | $12,810 | 0 | $0 | $12,810 |
HASTINGS PAUL J | director | 0 | $0 | 1 | $24,974 | $-24,974 |
GAUGLER DARYL | Chief Operating Officer | 0 | $0 | 3 | $44,690 | $-44,690 |
RIKER LAUREN | Senior Vice President, Finance | 0 | $0 | 1 | $114,018 | $-114,018 |
WILLIAMS KRISTEN | Chief Administrative Officer | 0 | $0 | 1 | $211,488 | $-211,488 |
SLONIN JONATHAN | Chief Medical Officer | 0 | $0 | 4 | $258,431 | $-258,431 |
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that …
Over the last 12 months, insiders at Pacira BioSciences, Inc. have bought $215,684 and sold $653,601 worth of Pacira BioSciences, Inc. stock.
On average, over the past 5 years, insiders at Pacira BioSciences, Inc. have bought $215,684 and sold $17.1M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Lee Frank D. (Chief Executive Officer) — $99,994. BIGAL MARCELO (director) — $60,868. YANG MICHAEL J. (director) — $25,800.
The last purchase of 1,512 shares for transaction amount of $20,034 was made by BIGAL MARCELO (director) on 2024‑08‑16.
2025-01-06 | Sale | SLONIN JONATHAN | Chief Medical Officer | 879 0.0019% | $18.40 | $16,174 | +33.25% | |
2024-12-13 | Sale | GAUGLER DARYL | Chief Operating Officer | 500 0.0011% | $19.76 | $9,880 | +17.04% | |
2024-09-13 | Sale | GAUGLER DARYL | Chief Operating Officer | 500 0.0011% | $12.86 | $6,430 | +43.10% | |
2024-08-16 | Brege Laura | director | 1,000 0.0023% | $12.81 | $12,810 | +36.24% | ||
2024-08-16 | BIGAL MARCELO | director | 1,512 0.0036% | $13.25 | $20,034 | +36.24% | ||
2024-08-14 | YANG MICHAEL J. | director | 2,000 0.0046% | $12.90 | $25,800 | +40.74% | ||
2024-08-12 | Lee Frank D. | Chief Executive Officer | 8,264 0.0178% | $12.10 | $99,994 | +42.39% | ||
2024-08-12 | Froimson Mark | director | 1,400 0.0029% | $11.58 | $16,212 | +42.39% | ||
2024-08-12 | BIGAL MARCELO | director | 3,400 0.0073% | $12.01 | $40,834 | +42.39% | ||
2024-08-02 | Sale | SLONIN JONATHAN | Chief Medical Officer | 945 0.0019% | $20.05 | $18,947 | -17.45% | |
2024-07-02 | Sale | SLONIN JONATHAN | Chief Medical Officer | 2,836 0.0062% | $28.25 | $80,117 | -17.15% | |
2024-06-13 | Sale | GAUGLER DARYL | Chief Operating Officer | 1,000 0.0021% | $28.38 | $28,380 | -32.32% | |
2024-06-13 | Sale | WILLIAMS KRISTEN | Chief Administrative Officer | 7,452 0.0157% | $28.38 | $211,488 | -32.32% | |
2024-06-13 | Sale | HASTINGS PAUL J | director | 880 0.0019% | $28.38 | $24,974 | -32.32% | |
2024-06-12 | Sale | RIKER LAUREN | Senior Vice President, Finance | 3,970 0.0085% | $28.72 | $114,018 | -32.93% | |
2024-06-11 | Sale | SLONIN JONATHAN | Chief Medical Officer | 5,012 0.0106% | $28.57 | $143,193 | -33.48% | |
2024-03-08 | Sale | PACE GARY W | director | 90,000 0.1889% | $30.60 | $2.75M | -32.73% | |
2024-03-07 | Sale | PACE GARY W | director | 28,257 0.0613% | $30.81 | $870,598 | -30.83% | |
2024-03-06 | Sale | PACE GARY W | director | 1,066 0.0023% | $29.67 | $31,628 | -29.61% | |
2023-08-02 | Sale | WINSTON ROY | Chief Medical Officer | 509 0.0011% | $34.88 | $17,751 | -19.83% |
Lee Frank D. | Chief Executive Officer | 107784 0.2329% | $2.47M | 1 | 0 | |
Brege Laura | director | 17552 0.0379% | $401,414.24 | 1 | 6 | |
Froimson Mark | director | 14473 0.0313% | $330,997.51 | 2 | 2 | <0.0001% |
HASTINGS PAUL J | director | 12724 0.0275% | $290,997.88 | 1 | 18 | +79.52% |
BIGAL MARCELO | director | 10142 0.0219% | $231,947.54 | 2 | 0 |
$910,099,463 | 123 | 11.52% | $2.63B | |
$187,390,806 | 89 | 12.63% | $777.44M | |
$12,681,496 | 70 | 20.90% | $804.92M | |
$14,599,168 | 59 | 12.79% | $1.36B | |
$23,522,750 | 59 | -6.74% | $5.16B |
Increased Positions | 114 | +39.86% | 8M | +15.58% |
Decreased Positions | 122 | -42.66% | 10M | -18.54% |
New Positions | 37 | New | 3M | New |
Sold Out Positions | 44 | Sold Out | 2M | Sold Out |
Total Postitions | 278 | -2.8% | 50M | -2.96% |
Blackrock, Inc. | $185,421.00 | 16.76% | 7.71M | -77,580 | -1% | 2024-12-31 |
Vanguard Group Inc | $126,597.00 | 11.44% | 5.26M | -34,764 | -0.66% | 2024-12-31 |
Pacer Advisors, Inc. | $78,471.00 | 7.09% | 3.26M | -2M | -34.25% | 2024-12-31 |
D. E. Shaw & Co., Inc. | $54,292.00 | 4.91% | 2.26M | +300,536 | +15.36% | 2024-12-31 |
Renaissance Technologies Llc | $47,922.00 | 4.33% | 1.99M | +13,604 | +0.69% | 2024-12-31 |
State Street Corp | $47,270.00 | 4.27% | 1.97M | -48,544 | -2.41% | 2024-12-31 |
Dimensional Fund Advisors Lp | $44,065.00 | 3.98% | 1.83M | -40,154 | -2.15% | 2024-12-31 |
Doma Perpetual Capital Management Llc | $42,036.00 | 3.8% | 1.75M | 0 | 0% | 2024-12-31 |
Millennium Management Llc | $35,727.00 | 3.23% | 1.49M | +879,473 | +145.12% | 2024-12-31 |
Ubs Group Ag | $33,064.00 | 2.99% | 1.37M | +1M | +620.71% | 2024-12-31 |